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Abstract  
 
Background 
Despite its high prevalence, help-seeking for depression is low.  
 
Aims 
To assess the effectiveness and cost-effectiveness of one-day cognitive behaviour therapy (CBT) 
self-confidence workshops in reducing depression.  Anxiety, self-esteem, prognostic indicators as well 
as access were also assessed.  
 
Method 
An open randomised controlled trial (RCT) waitlist control design with 12 week follow-up was used. 
459 depressed adult participants (BDI scores of ≥ 14) self-referred and 382 (83%) participants were 
followed up. 
 
Results 
At follow-up, experimental and control participants differed significantly on the BDI, with an effect size 
of 0.55. Anxiety and self-esteem also differed. Participants included 25% GP non-consulters and 32% 
from BME groups. Women benefited more than men on depression. The intervention has a 90% 
chance of being considered cost-effective if a depression-free day is valued at £14. 
 
Conclusions 
Self-confidence workshops appear promising in terms of clinical effectiveness, cost-effectiveness and 
access by difficult to engage groups. 
 
Declaration of Interest 
None 
 
Trial registration ISRCTN 26634837 
Key words: CBT, depression, psychoeducational, black and ethnic minority groups, access, general 
public, cost-effectiveness. 
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Introduction (6763 words) 
By 2030, depression is forecast to be the leading cause of disease burden worldwide.1 Despite its 
high prevalence rates, numerous barriers prevent seeking and accessing help so that depression 
remains vastly undertreated.2 In the UK 54% of people experiencing a depressive episode did not 
contact their general practitioner (GP).3 In addition, although the public prefer psychological treatment 
over medication for depression,4 psychological services have been very limited.5  In the UK, access to 
psychological therapies is currently mostly via referral from a GP or a health professional. Despite a 
recent increase in funding, the capacity of psychological treatment services remains limited, 
particularly for people with moderate and severe problems (personal communication). In addition, 
black and minority ethnic (BME) groups are often under-represented in psychological therapy 
services6, as shown in the demonstration sites for the Improving Access to Psychological Therapies 
(IAPT) initiative in the UK. 7  
 
Cognitive behaviour therapy (CBT) is as effective as medication in moderately to severely depressed 
individuals, and has long-term benefits.8 Individual and group CBT for depression have comparable 
effectiveness.9 Clinical guidelines in the UK recommend intensive individual CBT for those with 
moderate or severe depression whereas individuals with mild to moderate depression who decline 
first line low intensity treatments (eg computerised CBT and guided self-help) should be offered group 
CBT.10 Traditional group CBT tends to be small scale, with 8-10 participants meeting for 10-12 two-
hour sessions. A credible alternative is to offer larger scale psychoeducational CBT groups that can 
reach more people. This approach has been successfully used with primary care patients with 
generalised anxiety who were offered evening classes11 and members of the public who self-referred 
to one-day stress workshops.12 However, psychoeducational interventions advertised as “depression” 
workshops had a lower uptake, attracting mostly people who had already used specialist services.13 
Changing the name of the workshops to a non-diagnostic label of “self-confidence” workshop led to a 
much higher uptake, with 39% of self-referrers never having previously consulted their GP for 
depression.14 A small randomised controlled trial of one-day self-confidence workshops versus a 
waiting list control found the intervention to be effective in reducing depression and improving self-
esteem after 12 weeks. A naturalistic follow-up study found that the benefits were maintained at two 
years but only for those who were depressed.15 So far, the effectiveness of these brief workshops has 
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only been demonstrated with a group of people varying in depression symptoms in one relatively 
deprived part of London, and no full economic evaluation has been undertaken. This study aims to 
assess if the self-confidence workshops can be effective and cost-effective in areas with different 
deprivation levels, focussing just on people with depression. If shown to be successful, this could 
provide an alternative effective and cost-effective psychological intervention for people with 
depression in the community, given the low take-up rates for treatment for depression and 
preferences for psychological treatment. 
 
 
Method 
Design 
A multicentre open RCT design was used, with self-confidence workshops run across eight boroughs 
in south London, with experimental and waiting list control arm participants followed up after 12 
weeks. Workshops were run between April 2010 and July 2011. Ethical approval was obtained from 
the King’s College Ethical Committee (Ref: PNM/09/10-65). 
The aims of the study were to:  
a) To assess whether the self-confidence workshops affected depression, the primary clinical 
outcome.  
b) To assess the effect of the workshops on the secondary clinical outcomes of anxiety and self-
esteem. 
c)  To investigate prognostic indicators of those who benefit most from the workshops.  
d)  To assess the proportion of participants from difficult to engage groups who accessed the 
intervention, specifically GP non-consulters and BME groups, in relation to local population 
distributions. 
e)  To assess whether the workshops were cost-effective compared to treatment as usual. 
 
Study setting 
The study was run in eight London boroughs. Using rank scores (range 1-326, where 1 indicates most 
deprived) derived from the Index of Multiple Deprivation 2010,16 in order of decreasing deprivation, 
the boroughs were: Greenwich (28), Lambeth (29), Lewisham (31), Croydon (107), Wandsworth 
(121), Bexley (174), Merton/Sutton (208), and Kingston upon Thames (255). Because of initial excess 
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attrition, Croydon and Lewisham were both revisited for a second workshop to ensure sufficient 
statistical power for outcome comparisons.  
 
Because workshops were designed to be accessible to the community, a self-referral process was 
used to recruit participants. Publicity was distributed for workshops two to three months before each 
introductory talk, which is where participants were recruited. A5 flyers advertising free one-day 
workshops entitled “How to improve your self-confidence” were posted to libraries, GP practices, 
community centres, leisure centres and pharmacies. The same advertisement was displayed in local 
magazines a few weeks before the introductory talk. Interested individuals were asked to email or 
telephone for further information and to register for the introductory talk.  
 
To maximise access, all workshops were held on Saturdays in non-mental health settings such as 
libraries, community centres or leisure centres. Venues also had good public transport links and 
disabled access. 
 
Participants 
Study participants had to be at least 18 years of age and depressed, as indicated by a BDI score of 
14 or above, as Beck and Steer17 recommend. Other exclusion criteria are given in the CONSORT 
diagram (Fig. 1) and included unavailability for the workshop dates and people attending the 
workshop together because of the possibility of “contamination” if they were randomised to different 
groups. We also excluded those who were unable to complete the baseline self-assessment 
questionnaires as well as, under “other”, those participants who had attention and concentration 
difficulties during the introductory talk. Research assistants and/or workshop leaders assessed 
participants against these criteria when registering or at the introductory talks. No exclusion criteria 
were specified in relation to antidepressants or concurrent psychological therapy. For ethical reasons, 
individuals who were not eligible or did not want to participate in the study were invited to attend 
workshops held on different dates to the study workshops.  
 
Intervention 
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The psychoeducational self-confidence workshop programme adopted for this study followed the 
previously piloted programme14 and used cognitive behavioural techniques largely based on Fennell’s 
model.18 Up to 30 people could attend each workshop. The day’s programme ran from 9.30 am to 
4.30 pm and was structured into four sessions. First, information was given about the development of 
low self-confidence and its emotional components, including depression. The second session 
consisted of cognitive components of low self-confidence, particularly identifying and challenging 
negative thoughts. Behavioural methods for improving low self-confidence, including problem solving 
and assertiveness, were taught in the third session. The final session was devoted to action planning, 
with participants setting their own homework targets to start improving their confidence. To reduce the 
possibility of participants becoming bored or tired, training methods were varied and included didactic 
sections, large group exercises, small group exercises, role-play demonstrations and discussions of 
vignettes of people with low self-confidence. Each participant was given a colourful 54 page A4 
workbook that covered the day’s programme to remind them of the methods taught. One month after 
the experimental arm workshop, participants were invited to a non-therapeutic two hour booster 
session run by the same workshop leaders to help consolidate learning. 
 
Workshops were run by two teams, each comprising two clinical or counselling psychologists, with 
two reserve psychologists providing cover in case of unavailability. Workshop leaders had an average 
of 3.5 (range 2-7) years’ post-qualification experience in delivering CBT. Workshop leaders received 
training in delivering the programme by undergoing a two-day training programme, in which they 
observed a workshop and then ran a workshop themselves under observation on a single day. The 
programme was manualised to ensure standardisation across boroughs. Workshop leaders also had 
bimonthly supervision, led by JSLB, to review any difficult situations.  
 
Measures 
Self-report questionnaires were administered at the introductory talk and 12 weeks after 
randomisation and comprised the following measures: 
Primary outcome measures 
Beck Depression Inventory-Second Edition (BDI-II, to be referred to as BDI)19 to measure severity of 
depression. BDI scores are normally categorised into non-depressed (BDI below 10), mildly 
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depressed (10-19), moderately depressed (20-28) and severely depressed (29 and above). An 
eligibility criterion used for this study was a BDI score of 14 and above.17 Cronbach’s alpha is 0.92 for 
clinical patients and 0.93 for non-clinical individuals19. For the economic evaluation, depression-free 
days (DFD) were calculated based on BDI scores at follow-up, using an algorithm suggested by Lave 
et al.20 A full DFD was assigned for BDI<10 and no DFD for BDI>28, with scores in between weighted 
proportionally. The maximum number of DFD over a three-month period is 91. 
 
Secondary outcome measures 
Generalised Anxiety Disorder 7 (GAD-7): a seven-item, four-point scale to assess anxiety. Cronbach’s 
alpha is 0.92.21  
Rosenberg Self-esteem Scale (RSES): a 10-item, four-point scale to measure changes in self-
esteem. Cronbach's alphas vary from 0.77 to 0.88.22 
EQ-5D: a measure of health-related quality of life.23 Health status is measured on five dimensions on 
three-point scales. The associated tariffs for England24 are then applied to calculate quality adjusted 
life years (QALYs). The instrument also includes a visual analogue scale (VAS), allowing individuals 
to rate their current health status on a scale from 0 (worst) to 100 (best). 
Client Service Receipt Inventory (CSRI).25 A self-report version of the measure, covering a 
retrospective three-month period, was adapted for the study to record use of services including 
hospital, primary care, specialist mental health and community based services such as social work 
and alternative therapy. It also records demographic information and details on employment to 
measure societal costs. In addition, it records if GPs had prescribed antidepressants for participants. 
Client Satisfaction Questionnaire (CSQ).26 This was completed at the end of each workshop, This 
eight-item scale measures satisfaction on a four-point scale. Cronbach's alpha for the scale is 0.92-
0.93.27 
 
Procedure  
All individuals who registered were invited to a one hour group introductory talk where further 
information about the workshops was given and informed consent obtained before participants 
completed baseline assessments. For those people who were unavailable for the talk, the research 
assistants offered an individual telephone assessment in the week either prior to or after the 
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introductory talk. Eligible participants were randomly allocated either to receive the workshop after 
three weeks (experimental arm) or to wait for 12 weeks for the workshop (control arm). One month 
after the experimental arm workshop, participants were invited to a non-therapeutic two hour booster 
group session run by the same workshop leaders to help consolidate learning. At follow-up, a two 
hour group meeting was held for experimental arm participants when outcome measures were 
completed at the beginning of the session, followed by a group discussion and signposting to other 
services as appropriate. Participants in the control arm were advised to see their GP as usual during 
the 12 week wait period. At 12 week follow-up, outcome measures for the control arm were collected 
immediately before they attended the workshop.  
 
Study participants who did not complete the assessments were posted outcome assessment 
questionnaires. This was followed up by telephone contact up to five times, as necessary. If there was 
no response, a final shortened assessment pack was posted.  
 
Sample size  
The calculated sample size for 90% power to detect an effect size of 0.46 was 320, or 160 in each 
arm. This was calculated assuming a 5% significance level, a two sided test, an attrition rate of 15%, 
and given the group intervention, a cluster size of 20 and an intraclass correlation coefficient of 0.05. 
Because the attrition level was higher than expected in the first three sites (32%), the target sample 
size was increased to 420 (210 per arm) to ensure adequate power.  
 
Randomisation and blinding 
Eligible participants were randomly assigned to one of the two treatment arms after baseline 
assessments were completed and consent obtained. Randomisation was performed using an online 
randomisation system provided by the King’s Clinical Trials Unit (CTU) at the Institute of Psychiatry, 
King’s College London. Randomisation was stratified by gender, self-reported ethnicity (white/other), 
depression (BDI mild, moderate and severe categories) and borough. Minimisation was used to 
reduce any imbalance on these features across the two arms. Simple randomisation was used for the 
first 32 participants and the minimisation algorithm utilised for the subsequent 427 participants. 
Research assistants electronically submitted details of each participant to the CTU and the 
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randomisation outcome was immediately returned electronically. An open design was used as 
blinding of arm allocation for research assistants and participants was not possible. However, the trial 
statistician’s blindness was maintained until the primary analysis.  
 
Statistical methods 
Stata version 10 was used for the main analysis. Variables were described using frequency and 
proportion or mean and standard deviation as appropriate.  
 
Participant characteristics 
Categorical variables were compared using Chi-square and Fisher’s exact tests. Continuous data 
were analysed using t-tests. Chi-square goodness of fit tests were used to compare our sample with 
the local population for each borough using information from the Office for National Statistics.28 
 
Clinical outcome analysis 
Clinical outcomes analysis was carried out following intention to treat (ITT) principles. Incomplete 
baseline and outcome BDI, GAD-7 and RSES questionnaires were prorated when 20% or less of the 
items were missing with the mean value of other responses used to replace the missing response. 
Categorical variables were compared using Fisher’s exact test.  
 
Adequate treatment completion was defined as experimental arm participants attending the full day-
long workshop and control arm participants not attending the earlier experimental workshop, A logistic 
regression model with an indicator variable for missing outcome data as the dependent variable was 
used to examine whether treatment non-completion and other variables predicted missing outcome. 
As this was the case, multiple imputation using chained equations was applied (Stata mi and mim 
commands).29 Imputation both allows for the inclusion of post-treatment variables that predict missing 
data, including completion of treatment and tends to be a more conservative analysis method. The 
imputation model covariates included an indicator variable for treatment completion, other variables 
associated with missing data, treatment arm, stratification factors (gender, ethnicity, borough), 
baseline and follow-up values of primary and secondary outcomes, and variables of interest for other 
secondary analyses. Thirty datasets were imputed and Rubin’s rules employed to obtain estimates.30 
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A sensitivity analysis for the multiple imputation using a missing at random (MAR) assumption 
examined the effect of adding a range of possible deviations to the ITT effect.31 As higher BDI scores 
indicate increased depression, deviation values which equated to the missing values being between 2 
and 20 points higher than the observed values in the experimental arm were tested. The analysis 
allowed the level of deviation at which the ITT effect would become non-significant to be quantified 
and the plausibility of such a deviation value to be evaluated.   
 
To assess differences in outcome, linear regression models were used. Mean differences between 
the treatment arms and associated 95% confidence intervals (CI) for the primary and secondary 
outcomes were estimated with the pertinent measure at follow-up as the dependent variable, with 
treatment arm, baseline score of the measure, and the other stratification factors as covariates. 
Confidence intervals for parameters were estimated using robust standard errors to account for 
clustering by workshop.  
 
The adjusted effect size was calculated as the mean difference between the two arms divided by the 
average root mean square error (RMSE) from models fit to each imputed dataset. 
 
Additional analyses included “per protocol analysis”, testing for an effect of therapist learning on BDI 
outcome over time and an exploration of baseline predictors of outcome BDI, using the imputed data. 
The “per protocol analysis” only included the treatment completers. The test for a trend was done 
using experimental arm data only and a continuous fixed effect for workshops numbered sequentially 
in time. The prognostic analysis explored whether various variables measured at baseline were 
predictive of outcome BDI. Manual forward stepwise regression was used to add variables to the base 
ITT analysis model; any variables with Wald F test P values of 0.2 or less when entered singly were 
considered further, and the variable with the smallest P value was added first. The process was 
halted when no further variables had a Wald F test P value of less than 0.05. Interaction terms 
between each of the potential prognostic variables that had been entered into the model and 
treatment arm were used to assess whether the treatment effect was moderated by any of these 
variables. Interaction terms significant at P<0.05 were retained. 
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Service costs and cost of the workshop intervention 
The costs of service use for each participant were calculated by identifying an appropriate unit cost 
and duration for each service contact reported on the CSRI and multiplying it by the number of 
contacts reported. Unit costs were drawn from publicly available sources 
(www.dh.gov.uk/health/tag/reference-costs)32 taken from previous studies or estimated using an 
equivalent method. Where service contacts were reported but the number of contacts was missing, 
the mean for all people in contact with that particular service was entered. Medication costs are based 
on net ingredient costs from the British National Formulary (www.bnf.org).  
 
The cost of providing the whole intervention (introductory talk, day-long workshop and booster 
session) was calculated from information provided by the research team. This included the cost of the 
venue, advertising, workshop materials, staff time (training, preparation, administration, delivering the 
intervention) and volunteer time.33 All costs are presented in 2010/11 prices. 
 
Cost-effectiveness and cost-utility analyses 
Stata version 12 was used for the economic analyses34. The cost-effectiveness and cost-utility of the 
workshops were explored using seemingly unrelated regression,35 using the sureg command. 
Separate regression models were fitted for (a) costs at follow-up and (b) each of the outcome 
measures considered in the economic evaluation (change in BDI, additional DFDs, QALY gain) as the 
dependent variable.36 
 
For each combination of cost and outcome, 10,000 bootstrap replications of the treatment group 
difference in costs and outcomes were generated and incremental cost-effectiveness ratios (ICERs) 
were calculated by dividing costs by the outcome. The probability, presented as a percentage, that 
the intervention is cost-effective was derived by calculating the proportion of incremental cost-
effectiveness ratios that indicated a cost-effective outcome for a range of values a funder or society 
may place on an outcome (“willingness to pay”, WTP). Plotting this probability against the 
corresponding values of WTP results in a cost-effectiveness acceptability curve (CEAC).37 The 
analysis of DFDs was used to illustrate differential cost-effectiveness for men and women. 
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Cost values for the sensitivity analysis were derived by varying the intervention cost based on 
different assumptions about attendance. The “base case” reflected individuals’ attendances as 
recorded by the researchers. A “worst case” scenario was created by applying to all sites a cost 
based on the lowest proportion of workshop attendance (46% of people attending the introductory 
talk) and the lowest observed proportion of booster session attendance (7%). A “best case” scenario 
was created by assuming that the workshops were run at 100% capacity, with 30 participants 
attending the workshop and booster sessions.  Cost-effectiveness acceptability curves (CEACs) were 
drawn for all three scenarios for QALY gains and change in BDI.  
 
Results 
Of the 1,042 individuals who enquired about the workshops, 734 were screened at the introductory 
talks or by telephone (Fig. 1). Of these, 37% were excluded, the most common reason being their BDI 
scores were less than 14. A total of 459 individuals were randomised into the experimental (n = 228) 
and control (n = 231) arms. Follow-up data were obtained for 83% of participants. Baseline 
characteristics of the participants were comparable between arms, except for a greater proportion 
being married in the control arm in addition to differences in employment status (Table 1). Data on 
service use, required for the cost-effectiveness analysis (CEA), were available for 380 participants 
(179 participants in the experimental and 201 in the control arms). There were no significant 
differences between the full and the CEA sample. 
 
Fig 1 about here 
Table 1 about here 
 
Participant characteristics 
In all eight boroughs, a higher percentage of females were recruited (80%) compared with the 
distribution in the community (51%). The average age of the recruited population was 44.1 years, 
similar to that across boroughs (44.0 years) (P>0.05).  
 
Across all boroughs, 25% had never consulted their GP before for psychological help, with no 
differences by borough (P=0.98).  
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Across the boroughs, there was a significant difference in the distributions across ethnic groups in the 
screened population compared to the borough population (χ2 90.8, df 4, P<0.001) (Table 2). The 
proportion of black ethnic groups self-referring was more than 1.5 times that of the local population in 
five boroughs. Further, the proportion of Asian participants was more than twice that in the local 
population in three boroughs. Finally, the proportion of mixed ethnic groups was more than twice that 
in the community in five boroughs.  
 
Table 2 about here 
 
There was a significant association between ethnic group and level of GP consultation, with those of 
black, Asian or other ethnic background more likely to be GP non-consulters than white or mixed 
ethnic groups (P=0.003). The rate of GP consultation was lowest in the Asian ethnic group (60%) and 
highest in the mixed ethnic group (82%). 
 
Severity of depression was also associated with level of GP consultation for depression. Significantly 
more people with severe depression (85%) had previously consulted a GP than those with milder 
symptoms (P<0.001). However, a post-hoc sub-group analysis by gender showed that the pattern 
held for females (mild depression, 59%; moderate, 71%; severe, 84%; P<0.001) but not for males 
(mild, 71%; moderate, 69%; severe, 88%; P=0.102).  
 
Clinical outcomes 
In all, 66% of experimental arm and 98% of control arm participants completed treatment (Fig. 1 and 
Table 3). The proportion of participants lost to follow-up was 8% greater in the experimental arm 
compared to the control arm (95% CI 1% to 14%, P=0.018), but there was no significant difference 
between the arms in the proportion actively withdrawing from the trial (Fig. 1, P=0.29). After prorating, 
follow-up BDI was missing for 48 (21%) experimental and 28 (12%) control participants. GAD-7 was 
missing in 56 (25%) and RSES missing in 57 (25%) experimental and both were missing in 37 (16%) 
of control participants (Table 4).   
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Table 3 about here 
 
All differences between the experimental and control arms on the primary (BDI) and secondary 
outcomes (GAD-7, RSES) were statistically significant (Fig. 2 and Table 4). The BDI scores of the 
experimental arm were 5.3 points lower compared to the control arm. This corresponds to an adjusted 
effect size of 0.55. Scores on GAD-7 were lower by 1.6, and RSES higher by 1.8, points in the 
experimental arm. In the per protocol analysis, BDI scores were 7.7 points lower in the experimental 
arm (95% CI -10.1 to -5.4). The MAR sensitivity analysis suggested the missing values in the 
experimental arm would have to average 18–20 points higher to render the difference between the 
arms to be non-significant, a difference which does not seem plausible (see web appendix).   
 
There was no evidence of therapist learning effect, with a non-significant decrease of 0.3 points in 
BDI for each additional workshop run (95% CI -0.8 to 0.3, P=0.28). 
 
Table 4 about here 
Fig. 2 about here 
 
In terms of prognostic factors, a higher baseline BDI was found to predict a higher outcome score 
(Table 5). Being categorised in an employment group other than paid employment was predictive of a 
worse outcome, but the only statistically significant difference was between housewife/husband and 
paid employment. Ethnicity did not predict outcome. However, the treatment effect was moderated by 
gender. The absolute BDI scores at the 12 week outcome for men in the experimental arm were non-
significantly lower by 1.7 points (95% CI -5.6 to 2.1) compared to those in the control arm, but women 
in the experimental arm scored significantly lower on the BDI by 6.4 points (95% CI -8.8 to -4.0) 
compared to those in the control arm. 
 
Table 5 about here 
 
The CSQ was completed by 90% (136 of 151) of experimental arm workshop attenders. Overall 
satisfaction with the workshops was very high, with 96% being mostly or very satisfied, and 96% 
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mostly or very satisfied with the amount of help received. Most (95%) said they generally or definitely 
received the help they wanted; 78% said most or almost all of their needs had been met, and 98% 
would recommend the programme to a friend. The service helped 94% deal more effectively with their 
problems and 93% would return to the service.  
 
Workshop cost 
The average total intervention cost per person in the experimental arm was £161 (SD £76) in the 
base case. In the best case scenario, it was £95 (SD £27) and in the worst case, it was £192 (SD 
£110).  
 
Service use and costs 
There were no statistically significant cost differences between the arms at baseline or follow-up, with 
the exception of the intervention cost. The total costs at baseline were £1,041 in the experimental arm 
and £1,050 in the control arm. The biggest contributor to total costs were hospital costs, although GPs 
were the most commonly used services with 45% in the experimental arm and 53% in the control arm 
reporting contacts at baseline. (See web appendix for full service use and cost tables.) 
 
At follow-up, total costs were £834 in the experimental arm (with intervention costs absorbing 19%) 
and £841 in the control arm. In the experimental arm, the cost of hospital services had decreased 
significantly over time. The reduction in primary care costs was significant in the control arm at the 
90% level.  
 
At baseline, around 20% of participants across both arms were in contact with counsellors and with 
mental health services such as psychologists. While the proportion in contact with specialist mental 
health services reduced (non-significantly) by about 5% in each arm at follow-up, the proportion in 
contact with counsellors remained the same. 
 
Average total costs for females were £1,136 (SD £173) at baseline and £849 (SD £88) at follow-up, 
while for males, these were £661 (SD £911) and £784 (SD £1,260), respectively. There were no 
statistically significant gender differences for the full sample, nor between arms. 
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Cost-effectiveness and cost-utility analyses 
Table 6 shows the average QALY gain, improvement in BDI and additional DFDs for the participants 
in the CEA sample. The QALY gain was small in both arms and there was no statistically significant 
difference.  
 
Table 6 
 
Figs. 3a and 3b shows the probability that the intervention would be considered cost-effective for 
various levels of WTP for a unit improvement in BDI and QALYs gained respectively, under base 
case, best case and worst case assumptions. 
 
Fig. 3a and 3b 
 
In the base case scenario, the probability that the intervention is cost-effective in terms of BDI 
improvement is 30% at a WTP of zero. This increases to 80% at a WTP of £30 and to over 99% at 
£70.  
 
Given the small QALY gain, the results of the cost-utility analysis are less promising. In the base 
case, the probability that the intervention is cost-effective first reaches a 50:50 chance at a WTP of 
£19,500 and does not exceed a probability of 56% even at higher values of WTP.  
 
Fig. 3 also shows the results of the sensitivity analysis (total costs adjusted using intervention costs 
estimated as best and worst case). The results do not change dramatically, with the relative shape of 
the curve remaining the same and the expected impact on the probability of cost-effectiveness. Full 
details can be found in table 5 in the web appendix. 
 
Looking at DFDs, findings from the cost-effectiveness analysis reflect the difference in BDI outcome 
(Fig. 4a). In the base case, at a WTP of £14 per DFD, the probability that the intervention is 
considered cost-effective is 90%. The sub-group analysis by gender (Fig. 4b) suggests that the 
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intervention is more likely to be considered cost-effective for men at lower values of WTP, with a 60% 
chance for men and only a 25% chance of cost-effectiveness for women at WTP of zero. However, 
with increasing values of WTP, the chance of cost-effectiveness for women increases steeply and 
exceeds that for men at a WTP of about £15. This reflects the significantly higher BDI improvement 
and (non-significantly) higher costs for women compared to men.    
 
Fig. 4a&4b 
 
Discussion 
This RCT shows that at 12 weeks, one-day psychoeducational self-confidence workshops are 
clinically effective at improving depression in a community sample recruited from areas of differing 
deprivation. Additionally, the workshops were effective at reducing levels of anxiety and increasing 
self-esteem. There was a differential effect of gender on depression outcome, whereby females 
benefited more from the workshops than males. The workshops attracted difficult to engage groups. A 
quarter of the participants had not previously consulted their GP for depression. A higher proportion of 
individuals from BME groups also participated than would be expected from the local population 
distribution.  
 
The economic analysis found no significant differences in baseline total support costs between the 
experimental and control arms. Based on depressive symptoms (BDI) and the related measure of 
depression-free days, the intervention has a high probability of being cost-effective, given a significant 
improvement in BDI in the experimental arm over and above the improvement seen in the control 
arm.  
 
Strengths and weaknesses 
There are several strengths to this study. This larger, rigorously conducted clinical trial extends the 
work of a preliminary RCT evaluating self-confidence workshops14 and shows that workshops 
targeted at depressed people attained an effect size of 0.55 on BDI. This compares favourably with 
the mean effect size of 0.31 that has been found in a meta-analysis of RCTs of psychological 
treatments for depression in primary care.38  
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The study had a large sample size and was multi-centre with the workshops covering some of the 
most deprived (eg Greenwich, Lambeth) and least deprived (eg Kingston upon Thames, 
Merton/Sutton) boroughs in England. The results are therefore likely to be generalisable to 
populations with varying levels of deprivation. 
 
A major strength was its accessibility. Using a self-referral system to attract depressed members of 
the public to the workshops was very successful, with the introductory talks oversubscribed in most 
boroughs. Importantly, 25% of the participants had never consulted their GP about their psychological 
problems, presumably either not seeing their GP about their depression or not raising their depression 
if they did consult. This finding is all the more remarkable given the common difficulties in engaging 
people with depression in treatment.2 This supports previous studies showing that providing an 
accessible alternative route can help improve help-seeking for depression by the public.39  
 
Notably, there was a higher proportion (32%) of participants from the BME groups than expected. 
Participants represented 1.5 times the BME population in five boroughs and twice the Asian 
population in three boroughs. This is remarkable given the reluctance of BME communities to consult 
their GPs for psychological problems and the low number using psychological services.6 However, it 
should be acknowledged that the borough figures cited only reflect the gender and ethnic breakdown 
and not necessarily the characteristics of the depressed populations. Of note though was that there 
were no ethnic differences in outcome. It should also be noted that black participants were not 
differentiated into African or Caribbean.  
 
A further strength was that the use of non-diagnostic labels attracted a large proportion (63%) of 
depressed people. This supports previous findings indicating that the use of non-diagnostic labels, 
such as “self-confidence” rather than depression or “sleep” rather than insomnia, can be important in 
engaging groups who may prefer not to medicalise mental health problems.39 The general public have 
been shown to conceptualise depressive symptoms as “problems of living” rather than symptoms of a 
mental illness.40 It may be that the offer of psychological intervention with a non-medical label 
provided an alternative route to psychological help more congruent with the health beliefs of the 
public. 
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There are several methodological strengths of this trial. Stratified randomisation was used, pre-
randomisation allocation concealment was maintained, the statistician blinded prior to analysis, and 
analyses were performed on an ITT basis.  
 
Some limitations were that only self-report measures were used, so that the assessment of 
depression is reliant on this rather than by clinical interview. However, clinical diagnostic interviews for 
depression were not feasible given the large community samples. The workshops also attracted quite 
a high proportion of graduates (44%), possibly biasing the results. 
 
Another limitation was that the attrition rate at the beginning of the study was 32% but was improved 
to 16% so that data for 83% of participants were available at follow-up. However, a sensitivity analysis 
for the missing at random (MAR) assumption made by multiple imputation methods indicated that the 
missing participants would have had to have scored incredibly higher or lower compared to those who 
did return data in order to render the result non-significant. The follow-up rate for the control arm was 
higher than for the experimental arm, probably in part because the control arm completed their 
questionnaires when they arrived for their intervention rather than 12 weeks after the experimental 
arm workshop.  
 
Other weaknesses were that assessment of treatment quality and fidelity was only assessed through 
observation of two workshops run by newly trained leaders. This workshop seemed to appeal to 
women much more than men, and also seemed to be more helpful to women. Finally, limitations were 
a lack of a placebo control so that expectancy was not controlled, and follow-up data were only 
collected after three months.  
 
While the cost-effectiveness findings are encouraging for the depression-specific measure, the 
intervention is unlikely to be considered cost-effective in terms of QALYs given the small QALY 
improvement. Additionally, QALYs are a generic measure of health-related quality of life that 
facilitates comparability across interventions and conditions and it has been argued41 that they may 
not be sensitive enough to assess changes resulting from interventions targeting mental, rather than 
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physical, health. Only one of the five EQ-5D dimensions relates directly to mental health 
(anxiety/depression), so in this study a very large improvement in this domain would have been 
required to generate a significant improvement in the overall measure.  
 
Comparison with other studies 
As this psychoeducational intervention differs substantially from other programmes for depression, 
particularly in terms of content and the one-day format, direct comparisons are difficult. This section 
will therefore focus on the comparison of effectiveness of this intervention with other primary care 
interventions for depression.  
 
The effect size of these self-confidence workshops plus booster compared favourably with other 
primary care interventions. It is higher than that of a traditional 12 session “Coping with Depression” 
course, which a meta-analysis found to have a mean effect size of only 0.28.42 It also compares well 
with computerised CBT for depressive symptoms where a meta-analysis found an effect size of 
0.32.43 Similarly, collaborative care which involves shared care between the primary care physician, 
psychiatrist and psychologist, with the patient involved in making decisions has been found to be 
effective. However, the overall effect size for this approach was reported as 0.20-0.29.44 
 
The self-confidence workshop intervention compares very favourably with self-help without additional 
guidance, where an effect size of 0.28 was found in a recent meta-analysis.45 However, guided self-
help, which offers CBT materials with some support from a health professional fared better, with an 
effect size of 0.80.46  
 
One may speculate on reasons for the comparative effectiveness of the workshops. One is that the 
group support offered in the workshops could have been important, especially when compared to 
computerised CBT. Collaborative care could be as effective or ineffective as the quality of local 
services available. It is interesting that the small group depression course had a lower effect size but 
this could be attributed to differences in the course as the self-confidence workshops used cognitive 
as well as behavioural methods. Finally the larger effect size obtained by guided self-help may be the 
result of being able to provide detailed follow-up of individual goals over several weeks which is not 
possible with a one-day programme.  
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The cost-effectiveness findings based on BDI improvement compare favourably to computerised CBT 
for anxiety and depression in primary care.47 From a societal perspective (including lost employment) 
the base case scenario for computerised CBT showed a 14% probability that the intervention was 
cost-effective at a WTP of zero. This increased to over 80% at WTP values over £40 and to over 90% 
at a WTP of £80, In comparison, the psychoeducational workshops showed a higher probability of 
cost-effectiveness of( 30% at a WTP of zero, which increased to 80% at a WTP of £30 and to 95% at 
£50.  
 
However, when looking at DFDs, the probability that the computerised CBT intervention would be 
considered cost-effective was 80% at a WTP of £5 per DFD compared to only 54% for the workshops, 
Further, the rate at which the probability of cost-effectiveness increases as WTP rises is slower for the 
workshops than for computerised CBT. It has to be noted, however, that our estimate of DFDs is fairly 
crude. It is based on only two values for BDI, whereas in the computerised CBT study, BDI data were 
collected at five time points over a six month period. 
 
The current trial compares favourably with a study comparing CBT with usual care and talking therapy 
for older people48  which found a cost of £120 per point reduction in BDI and a 90% probability that 
CBT would be considered cost-effective at a WTP of £270. In the current study, the 90% probability 
was reached at a WTP of only £40 in the base case. 
 
Comparison with studies that do not present cost-effectiveness acceptability curves is not 
straightforward, but cost per DFD is a commonly reported comparable measure. A recent review of 
collaborative care interventions in primary care reported costs per DFD of between $20- $24,49 
equivalent to approximately £14 (using Purchasing Power Parity data for 2010 prices; stats.oecd.org). 
At this value of WTP, the probability that the self-confidence workshops would be considered cost-
effective is 80% in the base case, suggesting that the cost per DFD of self-confidence workshops is 
broadly the same as for collaborative care interventions.  
 
Service implications 
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The self-confidence workshops approach could well help the under-treatment of depression. It could 
provide a viable and effective alternative way for the public to directly access a brief and acceptable 
psychological intervention for depression, by offering early intervention to those who are reluctant to 
seek help from their GPs, such as those from BME communities, in areas of varying social 
deprivation. It could also help circumvent the common problem of under-detection of depression in 
primary care.3  
 
Given the dearth of evidence on the cost-effectiveness of interventions for depression, this study is a 
valuable contribution to the evidence base. The intervention is relatively cheap to provide at around 
£161 per participant, and there is no associated increase in other support costs. It should therefore be 
considered a cost-effective way of engaging people who receive little in terms of other support, 
despite high levels of distress. It is a promising option that could further the aims of the IAPT services 
in the UK. 
 
Future research 
It would be helpful to replicate these findings and investigate the effectiveness and cost-effectiveness 
of these day-long self-confidence workshops using a placebo control workshop where participants 
attend for a day, but are given an alternative treatment for depression or alternatively a control 
condition where expectancy is controlled, such as a health education programme.  It would also be 
useful to examine the longer-term effectiveness of these workshops over at least a year, even though 
a naturalistic follow-up indicated that the effects were maintained after two years by those who were 
depressed.15 
 
An examination of which methods participants found particularly useful and actually put into practice 
would also be informative. These components could be studied further to see which mediate the 
treatment effect in order to better tailor future workshops. It would be useful to run workshops in areas 
where there are figures for local psychiatric morbidity figures. It would also be useful to attract non-
graduate difficult to engage groups to see if this affects results. 
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In this study, gender affected uptake and outcome. Whilst the prevalence of depression is higher 
among women, women are more likely to perceive a need for mental health care than men.50 Men 
may be more reluctant, possibly because of male gender-role expectations and gender-related health 
concepts which hinder help-seeking.50 Depressed men have also been found to present fewer 
symptoms and cope differently.51 In this study, we found that men tended more often to have 
consulted their GPs with mild depression, which is often difficult to detect in primary care. Further 
work to develop interventions that will both appeal and effectively help depressed men would be 
important.  
 
Finally, further research around the health beliefs of the general public could lead to the use of 
acceptable “labels” that would appeal to men and women, which could in turn lead to the development 
of more large-scale psychological health interventions for the public. 
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